{"source": "EMA documents JSON (filtered)", "days": 3, "cutoff_utc": "2025-12-16T06:24:49.114382+00:00", "count": 202, "debug_skipped_str": 0, "debug_skipped_other": 0, "items": [{"id": "61627", "name": "Agamree : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2024-01-04T14:26:31Z", "last_update_date": "2025-12-16T16:25:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/agamree-epar-product-information_en.pdf"}, {"id": "63205", "name": "Agamree : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2024-05-13T16:29:00Z", "last_update_date": "2025-12-16T12:09:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/agamree-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71762", "name": "Agamree : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T08:19:07Z", "last_update_date": "2025-12-16T08:19:07Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/agamree-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "67446", "name": "Agamree : EPAR - Product information - tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-03-25T16:52:21Z", "last_update_date": "2025-12-16T08:20:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/agamree-epar-product-information-tracked-changes_en.docx"}, {"id": "49673", "name": "Libmeldy : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2020-12-22T11:01:00Z", "last_update_date": "2025-12-16T16:32:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/libmeldy-epar-product-information_en.pdf"}, {"id": "69535", "name": "Libmeldy : EPAR - Procedural steps taken and scientific information after the authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-07-28T14:19:29Z", "last_update_date": "2025-12-16T15:08:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/libmeldy-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "8689", "name": "Cholib : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2013-09-18T02:00:00Z", "last_update_date": "2025-12-16T10:28:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/cholib-epar-product-information_en.pdf"}, {"id": "21306", "name": "Cholib : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2014-04-09T02:00:00Z", "last_update_date": "2025-12-16T10:29:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/cholib-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71763", "name": "Cholib : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T08:30:30Z", "last_update_date": "2025-12-16T08:30:30Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/cholib-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "45055", "name": "Ambrisentan Viatris : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2019-07-15T10:03:00Z", "last_update_date": "2025-12-16T10:38:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/ambrisentan-viatris-epar-product-information_en.pdf"}, {"id": "47092", "name": "Ambrisentan Viatris : EPAR - Procedural steps taken and scientific information after the authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2020-03-20T17:26:00Z", "last_update_date": "2025-12-16T10:05:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/ambrisentan-viatris-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71764", "name": "Ambrisentan Viatris : EPAR - Procedural steps taken and scientific information after the authorisation ", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T08:35:23Z", "last_update_date": "2025-12-16T08:35:23Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/ambrisentan-viatris-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71765", "name": "Trisenox : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T08:41:07Z", "last_update_date": "2025-12-16T08:41:07Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/trisenox-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71766", "name": "Trisenox : EPAR – Product information - tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T08:42:55Z", "last_update_date": "2025-12-16T08:42:55Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/trisenox-epar-product-information-tracked-changes_en.docx"}, {"id": "41149", "name": "Protopic : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-07-06T02:00:00Z", "last_update_date": "2025-12-16T12:15:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/protopic-epar-product-information_en.pdf"}, {"id": "20642", "name": "Opsumit : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2014-02-07T12:47:00Z", "last_update_date": "2025-12-16T14:09:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/opsumit-epar-product-information_en.pdf"}, {"id": "67633", "name": "\tOpsumit : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-04T13:01:04Z", "last_update_date": "2025-12-16T09:25:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/opsumit-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "10278", "name": "Cyanokit : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2009-04-20T02:00:00Z", "last_update_date": "2025-12-16T14:19:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/cyanokit-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "14307", "name": "Cyanokit : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-04-20T02:00:00Z", "last_update_date": "2025-12-16T14:22:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/cyanokit-epar-product-information_en.pdf"}, {"id": "71767", "name": "Cyanokit : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T09:29:35Z", "last_update_date": "2025-12-16T09:29:35Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/cyanokit-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "60989", "name": "New product information wording – Extracts from PRAC recommendations on signals adopted at the 23-26 October PRAC", "type": "prac-recommendation", "status": "unknown", "consultation_date": "", "publish_date": "2023-11-20T13:42:36Z", "last_update_date": "2025-12-16T09:35:12Z", "reference_number": "EMA/PRAC/477437/2023", "url": "https://www.ema.europa.eu/en/documents/prac-recommendation/new-product-information-wording-extracts-prac-recommendations-signals-adopted-23-26-october-prac_en.pdf"}, {"id": "23101", "name": "Pramipexole Teva : EPAR - Summary for the public", "type": "overview", "status": "unknown", "consultation_date": "", "publish_date": "2009-03-10T01:00:00Z", "last_update_date": "2025-12-16T09:34:25Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/overview/pramipexole-teva-epar-summary-public_en.pdf"}, {"id": "62004", "name": "New product information wording – Extracts from PRAC recommendations on signals adopted at the 8-11 January 2024 PRAC", "type": "prac-recommendation", "status": "unknown", "consultation_date": "", "publish_date": "2024-02-05T16:13:47Z", "last_update_date": "2025-12-16T09:45:12Z", "reference_number": "EMA/PRAC/2749/2024", "url": "https://www.ema.europa.eu/en/documents/prac-recommendation/new-product-information-wording-extracts-prac-recommendations-signals-adopted-8-11-january-2024-prac_en.pdf"}, {"id": "71768", "name": "Opsumit : EPAR – Product information - tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T09:46:55Z", "last_update_date": "2025-12-16T09:46:55Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/opsumit-epar-product-information-tracked-changes_en.docx"}, {"id": "61643", "name": "New product information wording – Extracts from PRAC recommendations on signals adopted at the 27-30 November 2023 PRAC", "type": "prac-recommendation", "status": "unknown", "consultation_date": "", "publish_date": "2024-01-05T15:12:46Z", "last_update_date": "2025-12-16T09:45:10Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/prac-recommendation/new-product-information-wording-extracts-prac-recommendations-signals-adopted-27-30-november-2023-prac_en.pdf"}, {"id": "62773", "name": "New product information wording – Extracts from PRAC recommendations on signals adopted at the 4-7 March 2024 PRAC", "type": "prac-recommendation", "status": "unknown", "consultation_date": "", "publish_date": "2024-04-02T11:15:27Z", "last_update_date": "2025-12-16T09:48:59Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/prac-recommendation/new-product-information-wording-extracts-prac-recommendations-signals-adopted-4-7-march-2024-prac_en.pdf"}, {"id": "71769", "name": "Ventavis : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T09:51:58Z", "last_update_date": "2025-12-16T09:51:58Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/ventavis-epar-risk-management-plan_en.pdf"}, {"id": "41137", "name": "Ventavis : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2009-07-03T03:00:00Z", "last_update_date": "2025-12-16T14:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/ventavis-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71770", "name": "Ventavis : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T09:57:21Z", "last_update_date": "2025-12-16T09:57:21Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/ventavis-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "10180", "name": "Quality Review of Documents (QRD) working group plenary meeting dates", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2023-12-05T16:18:00Z", "last_update_date": "2025-12-16T16:10:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/quality-review-documents-qrd-working-group-plenary-meeting-dates_en.pdf"}, {"id": "55873", "name": "Sunlenca : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2022-08-25T14:42:00Z", "last_update_date": "2025-12-16T15:19:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/sunlenca-epar-product-information_en.pdf"}, {"id": "59097", "name": "Sunlenca : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2023-06-27T08:40:00Z", "last_update_date": "2025-12-16T15:20:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/sunlenca-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71771", "name": "Sunlenca : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T10:33:24Z", "last_update_date": "2025-12-16T10:33:24Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/sunlenca-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71772", "name": "Start of procedure: Extension of marketing authorisation (14 November - 11 December 2025)", "type": "report", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T10:33:58Z", "last_update_date": "2025-12-16T10:33:58Z", "reference_number": "EMA/392654/2025", "url": "https://www.ema.europa.eu/en/documents/report/start-procedure-extension-marketing-authorisation-14-november-11-december-2025_en.xlsx"}, {"id": "71773", "name": "Start of procedure: Type II variation - Extension of indication under evaluation by the CHMP (14 November - 11 December 2025)", "type": "report", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T10:36:46Z", "last_update_date": "2025-12-16T10:36:46Z", "reference_number": "EMA/392653/2025", "url": "https://www.ema.europa.eu/en/documents/report/start-procedure-type-ii-variation-extension-indication-under-evaluation-chmp-14-november-11-december-2025_en.xlsx"}, {"id": "50889", "name": "Kesimpta : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2021-04-16T15:26:00Z", "last_update_date": "2025-12-16T09:12:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/kesimpta-epar-product-information_en.pdf"}, {"id": "51347", "name": "Kesimpta : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2021-06-02T16:08:00Z", "last_update_date": "2025-12-16T09:12:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/kesimpta-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71774", "name": "Kesimpta : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T11:46:39Z", "last_update_date": "2025-12-16T11:46:39Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/kesimpta-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "3041", "name": "Erelzi : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2017-06-29T02:00:00Z", "last_update_date": "2025-12-16T16:32:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/erelzi-epar-product-information_en.pdf"}, {"id": "71324", "name": "Erelzi : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-11-25T09:29:03Z", "last_update_date": "2025-12-16T12:12:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/erelzi-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "70177", "name": "Questions and answers on the withdrawal of application for the marketing authorisation of Omforro (midazolam)", "type": "medicine-qa", "status": "unknown", "consultation_date": "", "publish_date": "2025-09-19T08:47:25Z", "last_update_date": "2025-12-16T12:38:08Z", "reference_number": "EMA/300796/2025", "url": "https://www.ema.europa.eu/en/documents/medicine-qa/questions-answers-withdrawal-application-marketing-authorisation-omforro-midazolam_en.pdf"}, {"id": "71776", "name": "Withdrawal assessment report for Omforro", "type": "withdrawal-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-16T12:37:32Z", "last_update_date": "2025-12-16T12:37:32Z", "reference_number": "EMADOC-1829012207-24322", "url": "https://www.ema.europa.eu/en/documents/withdrawal-report/withdrawal-assessment-report-omforro_en.pdf"}, {"id": "50813", "name": "Seffalair Spiromax : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2021-04-13T16:39:00Z", "last_update_date": "2025-12-16T11:08:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/seffalair-spiromax-epar-product-information_en.pdf"}, {"id": "67621", "name": "Seffalair Spiromax : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-03T13:31:19Z", "last_update_date": "2025-12-16T13:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/seffalair-spiromax-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71777", "name": "Seffalair Spiromax : EPAR – Product information - tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T12:58:12Z", "last_update_date": "2025-12-16T12:58:12Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/seffalair-spiromax-epar-product-information-tracked-changes_en.docx"}, {"id": "71779", "name": "EMA/PE/0000221500 : EMA decision of 5 December 2024 on the refusal of a paediatric investigation plan and on the granting of a waiver for Phleum pratense pollen extract", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-16T13:17:09Z", "last_update_date": "2025-12-16T13:17:09Z", "reference_number": "EMADOC-1700519818-1792191", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221500-ema-decision-5-december-2024-refusal-paediatric-investigation-plan-granting-waiver-phleum-pratense-pollen-extract_en.pdf"}, {"id": "71780", "name": "EMA/PE/0000221511 : EMA decision of 6 December 2024 on the granting of a product specific waiver for recombinant human apolipoprotein A-I", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-16T13:34:48Z", "last_update_date": "2025-12-16T13:34:48Z", "reference_number": "EMADOC-1700519818-1793267", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221511-ema-decision-6-december-2024-granting-product-specific-waiver-recombinant-human-apolipoprotein-i_en.pdf"}, {"id": "71781", "name": "EMA/PE/0000221664 : EMA decision of 6 December 2024 on the refusal of a paediatric investigation plan and on the granting of a waiver for parietaria judaica pollen extract", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-16T13:45:06Z", "last_update_date": "2025-12-16T13:45:06Z", "reference_number": "EMADOC-1700519818-1793193", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221664-ema-decision-6-december-2024-refusal-paediatric-investigation-plan-granting-waiver-parietaria-judaica-pollen-extract_en.pdf"}, {"id": "71782", "name": "EMA/PE/0000221674 : EMA decision of 6 December 2024 on the granting of a product specific waiver for xaluritamig", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-16T13:54:35Z", "last_update_date": "2025-12-16T13:54:35Z", "reference_number": "EMADOC-1700519818-1793219", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221674-ema-decision-6-december-2024-granting-product-specific-waiver-xaluritamig_en.pdf"}, {"id": "71783", "name": "EMA/PE/0000221695 : EMA decision of 5 December 2024 on the refusal of a paediatric investigation plan and on the granting of a waiver for Cupressus arizonica pollen extract", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-16T14:07:28Z", "last_update_date": "2025-12-16T14:07:28Z", "reference_number": "EMADOC-1700519818-1792235", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221695-ema-decision-5-december-2024-refusal-paediatric-investigation-plan-granting-waiver-cupressus-arizonica-pollen-extract_en.pdf"}, {"id": "71784", "name": "EMA/PE/0000221772 : EMA decision of 6 December 2024 on the refusal of a paediatric investigation plan and on the granting of a waiver for Olea europaea pollen extract", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-16T14:10:37Z", "last_update_date": "2025-12-16T14:10:37Z", "reference_number": "EMADOC-1700519818-1790725", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221772-ema-decision-6-december-2024-refusal-paediatric-investigation-plan-granting-waiver-olea-europaea-pollen-extract_en.pdf"}, {"id": "71785", "name": "EMA/PE/0000221419 : EMA decision of 6 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for Pneumococcal Polysaccharide Serotype 3 – Diphtheria CRM197 Conjugate...", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-16T14:39:47Z", "last_update_date": "2025-12-16T14:39:47Z", "reference_number": "EMADOC-1700519818-1793577", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221419-ema-decision-6-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-pneumococcal-polysaccharide-serotype-3-diphtheria-crm197-conjugate_en.pdf"}, {"id": "68471", "name": "Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2025", "type": "regulatory-procedural-guideline", "status": "Adopted", "consultation_date": "", "publish_date": "2025-05-27T14:36:42Z", "last_update_date": "2025-12-16T09:52:00Z", "reference_number": "EMA/CVMP/PhVWP/101663/2025", "url": "https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/pharmacovigilance-related-regulatory-recommendations-centrally-authorised-veterinary-medicinal-products-during-2025_en.pdf"}, {"id": "20750", "name": "Matever : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2011-10-14T02:00:00Z", "last_update_date": "2025-12-16T17:09:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/matever-epar-product-information_en.pdf"}, {"id": "68326", "name": "Matever : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-05-16T14:40:34Z", "last_update_date": "2025-12-16T15:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/matever-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "54337", "name": "Ngenla : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2022-03-02T17:13:00Z", "last_update_date": "2025-12-16T10:29:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/ngenla-epar-product-information_en.pdf"}, {"id": "67939", "name": "Ngenla : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-23T14:53:36Z", "last_update_date": "2025-12-16T15:08:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/ngenla-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "60698", "name": "Pradaxa : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2023-03-22T14:24:00Z", "last_update_date": "2025-12-16T14:02:24Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/pradaxa-epar-risk-management-plan_en.pdf"}, {"id": "71786", "name": "EMA/PE/0000221485 : EMA decision of 6 December 2024 on the refusal of a modification of an agreed paediatric investigation plan for cangrelor tetrasodium (Kengrexal)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-16T15:18:03Z", "last_update_date": "2025-12-16T15:18:03Z", "reference_number": "EMADOC-1700519818-1792970", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221485-ema-decision-6-december-2024-refusal-modification-agreed-paediatric-investigation-plan-cangrelor-tetrasodium-kengrexal_en.pdf"}, {"id": "71778", "name": "EMA/PE/0000221424 : EMA decision of 6 December 2024 on the refusal of a paediatric investigation plan and on the granting of a product-specific waiver for dermatophagoides pteronyssinus extract", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-16T13:01:14Z", "last_update_date": "2025-12-16T13:01:14Z", "reference_number": "EMADOC-1700519818-1793274", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221424-ema-decision-6-december-2024-refusal-paediatric-investigation-plan-granting-product-specific-waiver-dermatophagoides-pteronyssinus-extract_en.pdf"}, {"id": "71787", "name": "EMA/PE/0000221199 : EMA decision of 6 December 2024 on the granting of a product specific waiver for bemcentinib", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-16T15:25:05Z", "last_update_date": "2025-12-16T15:25:05Z", "reference_number": "EMADOC-1700519818-1793576", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221199-ema-decision-6-december-2024-granting-product-specific-waiver-bemcentinib_en.pdf"}, {"id": "71788", "name": "eCTD v4.0 and EURSnext roadmap", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T15:46:04Z", "last_update_date": "2025-12-16T15:46:04Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/ectd-v40-eursnext-roadmap_en.pdf"}, {"id": "71750", "name": "Factsheet - Network reporting via the European Shortages Monitoring Platform (ESMP) during an MSSG-led preparedness action", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T15:57:00Z", "last_update_date": "2025-12-16T15:57:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/factsheet-network-reporting-european-shortages-monitoring-platform-esmp-during-mssg-led-preparedness-action_en.pdf"}, {"id": "71749", "name": "Factsheet - Network reporting via the European Shortages Monitoring Platform (ESMP) during a crisis", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T15:58:00Z", "last_update_date": "2025-12-16T15:58:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/factsheet-network-reporting-european-shortages-monitoring-platform-esmp-during-crisis_en.pdf"}, {"id": "71748", "name": "Factsheet - Industry reporting via the European Shortages Monitoring Platform (ESMP) during a crisis or MSSG-led preparedness action", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T19:57:07Z", "last_update_date": "2025-12-16T19:57:07Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/factsheet-industry-reporting-european-shortages-monitoring-platform-esmp-during-crisis-or-mssg-led-preparedness-action_en.pdf"}, {"id": "63569", "name": "European Shortages Monitoring Platform (ESMP) Informational brief", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2024-06-11T13:48:32Z", "last_update_date": "2025-12-16T16:05:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/european-shortages-monitoring-platform-esmp-informational-brief_en.pdf"}, {"id": "64375", "name": "Frequently asked questions on the European Shortages Monitoring Platform (ESMP)", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2024-07-31T16:55:00Z", "last_update_date": "2025-12-16T18:10:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/frequently-asked-questions-european-shortages-monitoring-platform-esmp_en.pdf"}, {"id": "71789", "name": "Rivaroxaban Koanaa : EPAR - Medicine overview", "type": "overview", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T08:32:56Z", "last_update_date": "2025-12-17T08:32:56Z", "reference_number": "EMA/319706/2025", "url": "https://www.ema.europa.eu/en/documents/overview/rivaroxaban-koanaa-epar-medicine-overview_en.pdf"}, {"id": "71790", "name": "Rivaroxaban Koanaa : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T08:34:11Z", "last_update_date": "2025-12-17T08:34:11Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/rivaroxaban-koanaa-epar-risk-management-plan_en.pdf"}, {"id": "71791", "name": "Rivaroxaban Koanaa : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T08:35:16Z", "last_update_date": "2025-12-17T08:35:16Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/rivaroxaban-koanaa-epar-product-information_en.pdf"}, {"id": "71792", "name": "Rivaroxaban Koanaa : EPAR - All authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T08:36:21Z", "last_update_date": "2025-12-17T08:36:21Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/rivaroxaban-koanaa-epar-all-authorised-presentations_en.pdf"}, {"id": "71793", "name": "Rivaroxaban Koanaa : EPAR - Public assessment report", "type": "assessment-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T08:37:16Z", "last_update_date": "2025-12-17T08:37:16Z", "reference_number": "EMA/335639/2025", "url": "https://www.ema.europa.eu/en/documents/assessment-report/rivaroxaban-koanaa-epar-public-assessment-report_en.pdf"}, {"id": "60975", "name": "Product information URLs for member states", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2018-09-27T11:05:53Z", "last_update_date": "2025-12-17T08:45:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/product-information-urls-member-states_en.xls"}, {"id": "68248", "name": "Datroway : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-05-13T10:01:05Z", "last_update_date": "2025-12-17T15:20:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/datroway-epar-product-information_en.pdf"}, {"id": "68928", "name": "Datroway : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-06-24T15:20:38Z", "last_update_date": "2025-12-17T12:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/datroway-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71794", "name": "Rapiscan : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T09:25:16Z", "last_update_date": "2025-12-17T09:25:16Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/rapiscan-epar-risk-management-plan_en.pdf"}, {"id": "69946", "name": "Rapiscan : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-09-03T15:39:46Z", "last_update_date": "2025-12-17T09:26:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/rapiscan-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "15182", "name": "Tasigna : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-09-29T02:09:00Z", "last_update_date": "2025-12-17T17:21:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/tasigna-epar-product-information_en.pdf"}, {"id": "19599", "name": "Tasigna : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2009-10-08T02:09:00Z", "last_update_date": "2025-12-17T17:13:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/tasigna-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71795", "name": "Tasigna : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T09:58:40Z", "last_update_date": "2025-12-17T09:58:40Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/tasigna-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71796", "name": "Programme - eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course 2026", "type": "agenda", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T10:08:23Z", "last_update_date": "2025-12-17T10:08:23Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/agenda/programme-extended-eudravigilance-medicinal-product-dictionary-xevmpd-training-course-2026_en.pdf"}, {"id": "71797", "name": "Programme - eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course for sponsors 2026", "type": "agenda", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T10:19:52Z", "last_update_date": "2025-12-17T10:19:52Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/agenda/programme-extended-eudravigilance-medicinal-product-dictionary-xevmpd-training-course-sponsors-2026_en.pdf"}, {"id": "71798", "name": "EMA/PE/0000181219: EMA decision of 6 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for bedaquiline (fumarate) (Sirturo)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T11:30:47Z", "last_update_date": "2025-12-17T11:30:47Z", "reference_number": "EMADOC-1700519818-1775423", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000181219-ema-decision-6-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-bedaquiline-fumarate-sirturo_en.pdf"}, {"id": "71799", "name": "EMA/PE/0000181236: EMA decision of 5 December 2024 on the granting of a product specific waiver for telisotuzumab conjugated to (2S)-2-(2-bromoacetamido)-N-[(2S)-1-({3-[(7S)-7-ethyl-7-hydroxy-8,11-dioxo-7,8,11,13-tetrahydro-2H,10H-[1,3]dioxolo[4,5-g] ...", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T11:48:05Z", "last_update_date": "2025-12-17T11:48:05Z", "reference_number": "EMADOC-1700519818-1791510", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000181236-ema-decision-5-december-2024-granting-product-specific-waiver-telisotuzumab-conjugated-2s-2-2-bromoacetamido-n-2s-1-3-7s-7-ethyl-7-hydroxy-811-dioxo-781113-tetrahydro-2h10h_en.pdf"}, {"id": "11377", "name": "Adjupanrix : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-12-17T01:00:00Z", "last_update_date": "2025-12-17T01:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/adjupanrix-epar-product-information_en.pdf"}, {"id": "14742", "name": "Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals): EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2011-12-21T01:00:00Z", "last_update_date": "2025-12-17T15:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/adjupanrix-previously-pandemic-influenza-vaccine-h5n1-split-virion-inactivated-adjuvanted-glaxosmithkline-biologicals-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71800", "name": "Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals): EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T12:04:29Z", "last_update_date": "2025-12-17T12:04:29Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/adjupanrix-previously-pandemic-influenza-vaccine-h5n1-split-virion-inactivated-adjuvanted-glaxosmithkline-biologicals-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71801", "name": "EMA/PE/0000181238: EMA decision of 6 December 2024 on the agreement of a paediatric investigation plan and on the granting of a waiver for resiquimod", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T12:07:40Z", "last_update_date": "2025-12-17T12:07:40Z", "reference_number": "EMADOC-1700519818-1775491", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000181238-ema-decision-6-december-2024-agreement-paediatric-investigation-plan-granting-waiver-resiquimod_en.pdf"}, {"id": "71802", "name": "EMA/PE/0000181294: EMA decision of 6 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for tolebrutinib", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T12:23:45Z", "last_update_date": "2025-12-17T12:23:45Z", "reference_number": "EMADOC-1700519818-1766802", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000181294-ema-decision-6-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-tolebrutinib_en.pdf"}, {"id": "71803", "name": "EMA/PE/0000181300: EMA decision of 6 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for avalglucosidase alfa (Nexviadyme)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T12:31:22Z", "last_update_date": "2025-12-17T12:31:22Z", "reference_number": "EMADOC-1700519818-1793517", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000181300-ema-decision-6-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-avalglucosidase-alfa-nexviadyme_en.pdf"}, {"id": "71751", "name": "Factsheet - Industry reporting via the European Shortages Monitoring Platform (ESMP) in normal circumstances", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T15:54:00Z", "last_update_date": "2025-12-16T15:54:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/factsheet-industry-reporting-european-shortages-monitoring-platform-esmp-normal-circumstances_en.pdf"}, {"id": "71804", "name": "EMA/PE/0000221175 : EMA decision of 16 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for vibegron", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T12:57:00Z", "last_update_date": "2025-12-17T12:57:00Z", "reference_number": "EMADOC-1700519818-1807888", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221175-ema-decision-16-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-vibegron_en.pdf"}, {"id": "19866", "name": "QRD Appendix V - Adverse-drug-reaction reporting details", "type": "template-form", "status": "unknown", "consultation_date": "", "publish_date": "2013-03-15T17:00:00Z", "last_update_date": "2025-12-17T13:20:00Z", "reference_number": "EMA/67830/2013 Version 34", "url": "https://www.ema.europa.eu/en/documents/template-form/qrd-appendix-v-adverse-drug-reaction-reporting-details_en.docx"}, {"id": "56226", "name": "Agenda - ACT EU multi-stakeholder meeting on decentralised clinical trials", "type": "agenda", "status": "unknown", "consultation_date": "", "publish_date": "2022-09-28T10:58:00Z", "last_update_date": "2025-12-17T15:50:00Z", "reference_number": "EMA/789028/2022", "url": "https://www.ema.europa.eu/en/documents/agenda/agenda-act-eu-multi-stakeholder-meeting-decentralised-clinical-trials_en.pdf"}, {"id": "71806", "name": "Oxbryta Article-20 procedure - Assessment report", "type": "referral", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T14:01:49Z", "last_update_date": "2025-12-17T14:01:49Z", "reference_number": "EMA/354175/2025", "url": "https://www.ema.europa.eu/en/documents/referral/oxbryta-article-20-procedure-assessment-report_en.pdf"}, {"id": "71807", "name": "EMA/PE/0000220986 : EMA decision of 6 December 2024 on the granting of a product specific waiver for tenapanor", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T14:15:21Z", "last_update_date": "2025-12-17T14:15:21Z", "reference_number": "EMADOC-1700519818-1793255 Corr", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000220986-ema-decision-6-december-2024-granting-product-specific-waiver-tenapanor_en.pdf"}, {"id": "71808", "name": "EMA/PE/0000221021 : EMA decision of 6 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for atazanavir (sulphate) / cobicistat (EVOTAZ)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T14:19:52Z", "last_update_date": "2025-12-17T14:19:52Z", "reference_number": "EMADOC-1700519818-1793575", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221021-ema-decision-6-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-atazanavir-sulphate-cobicistat-evotaz_en.pdf"}, {"id": "71809", "name": "EMA/PE/0000181335: EMA decision of 5 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for budesonide / glycopyrronium bromide / formoterol (fumarate) (Trixeo Aerosphere)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T14:21:24Z", "last_update_date": "2025-12-17T14:21:24Z", "reference_number": "EMADOC-1700519818-1791535", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000181335-ema-decision-5-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-budesonide-glycopyrronium-bromide-formoterol-fumarate-trixeo-aerosphere_en.pdf"}, {"id": "71810", "name": "EMA/PE/0000181441: EMA decision of 6 December 2024 on the granting of a product specific waiver for telisotuzumab conjugated to (2S)-2-(2-bromoacetamido)-N-[(2S)-1-({3-[(7S)-7-ethyl-7-hydroxy-8,11-dioxo-7,8,11,13-tetrahydro-2H,10H-[1,3]dioxolo[4,5-g] ...", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T14:27:14Z", "last_update_date": "2025-12-17T14:27:14Z", "reference_number": "EMADOC-1700519818-1793529", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000181441-ema-decision-6-december-2024-granting-product-specific-waiver-telisotuzumab-conjugated-2s-2-2-bromoacetamido-n-2s-1-3-7s-7-ethyl-7-hydroxy-811-dioxo-781113-tetrahydro-2h10h_en.pdf"}, {"id": "71811", "name": "EMA/PE/0000221101 : EMA decision of 5 December 2024 on the granting of a product specific waiver for esepapogene zalarnarepvec", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T14:29:02Z", "last_update_date": "2025-12-17T14:29:02Z", "reference_number": "EMADOC-1700519818-1791979", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221101-ema-decision-5-december-2024-granting-product-specific-waiver-esepapogene-zalarnarepvec_en.pdf"}, {"id": "71812", "name": "EMA/PE/0000181518: EMA decision of 6 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for lerodalcibep", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T14:34:07Z", "last_update_date": "2025-12-17T14:34:07Z", "reference_number": "EMADOC-1700519818-1766926", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000181518-ema-decision-6-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-lerodalcibep_en.pdf"}, {"id": "71813", "name": "EMA/PE/0000221751 : EMA decision of 5 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for ascorbic acid, macrogol 3350, potassium chloride, sodium ascorbate, sodium chloride, sodium sulphate (Plenvu)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T14:41:20Z", "last_update_date": "2025-12-17T14:41:20Z", "reference_number": "EMADOC-1700519818-1792265", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221751-ema-decision-5-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-ascorbic-acid-macrogol-3350-potassium-chloride-sodium-ascorbate-sodium-chloride-sodium_en.pdf"}, {"id": "43389", "name": "Ocrevus : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2023-11-10T15:51:00Z", "last_update_date": "2025-12-17T16:08:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/ocrevus-epar-risk-management-plan_en.pdf"}, {"id": "68135", "name": "Ocrevus : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-05-06T18:32:15Z", "last_update_date": "2025-12-17T15:18:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/ocrevus-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71814", "name": "EMA/PE/0000181778: EMA decision of 6 December 2024 on the granting of a product specific waiver for rilvegostomig", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T14:50:39Z", "last_update_date": "2025-12-17T14:50:39Z", "reference_number": "EMADOC-1700519818-1793273", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000181778-ema-decision-6-december-2024-granting-product-specific-waiver-rilvegostomig_en.pdf"}, {"id": "10225", "name": "Entyvio : EPAR - All Authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2014-06-16T02:00:00Z", "last_update_date": "2025-12-17T02:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/entyvio-epar-all-authorised-presentations_en.pdf"}, {"id": "36026", "name": "Entyvio : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2014-06-16T12:00:00Z", "last_update_date": "2025-12-17T09:14:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/entyvio-epar-product-information_en.pdf"}, {"id": "67249", "name": "Entyvio : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-03-13T12:16:27Z", "last_update_date": "2025-12-17T15:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/entyvio-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71815", "name": "EMA/PE/0000182170: EMA decision of 5 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for regorafenib (Stivarga)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T15:09:08Z", "last_update_date": "2025-12-17T15:09:08Z", "reference_number": "EMADOC-1700519818-1791595", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000182170-ema-decision-5-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-regorafenib-stivarga_en.pdf"}, {"id": "71816", "name": "EMA/PE/0000182217: EMA decision of 6 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for cedazuridine / decitabine (Inaqovi)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T15:15:58Z", "last_update_date": "2025-12-17T15:15:58Z", "reference_number": "EMADOC-1700519818-1789714", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000182217-ema-decision-6-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-cedazuridine-decitabine-inaqovi_en.pdf"}, {"id": "71817", "name": "EMA/PE/0000182239: EMA decision of 19 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for setmelanotide (Imcivree) ", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T15:21:52Z", "last_update_date": "2025-12-17T15:21:52Z", "reference_number": "EMADOC-1700519818-1796893", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000182239-ema-decision-19-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-setmelanotide-imcivree_en.pdf"}, {"id": "71818", "name": "EMA/PE/0000182297: EMA decision of 6 December 2024 on the granting of a product specific waiver for oxybutynin", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T15:26:23Z", "last_update_date": "2025-12-17T15:26:23Z", "reference_number": "EMADOC-1700519818-1790205", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000182297-ema-decision-6-december-2024-granting-product-specific-waiver-oxybutynin_en.pdf"}, {"id": "71819", "name": "EMA/PE/0000182333: EMA decision of 6 December 2024 on the granting of a product specific waiver for precemtabart tocentecan", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T15:32:37Z", "last_update_date": "2025-12-17T15:32:37Z", "reference_number": "EMADOC-1700519818-1789267", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000182333-ema-decision-6-december-2024-granting-product-specific-waiver-precemtabart-tocentecan_en.pdf"}, {"id": "9718", "name": "Trumenba : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2017-06-06T02:00:00Z", "last_update_date": "2025-12-17T15:36:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/trumenba-epar-product-information_en.pdf"}, {"id": "67770", "name": "Trumenba : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-14T10:47:33Z", "last_update_date": "2025-12-17T16:29:38Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/trumenba-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71820", "name": "EMA/PE/0000182345: EMA decision of 6 December 2024 on the granting of a product specific waiver for inbakicept, nogapendekin alfa", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T15:40:57Z", "last_update_date": "2025-12-17T15:40:57Z", "reference_number": "EMADOC-1700519818-1790021", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000182345-ema-decision-6-december-2024-granting-product-specific-waiver-inbakicept-nogapendekin-alfa_en.pdf"}, {"id": "71821", "name": "Overview of (invented) names reviewed in November 2025 by the Name Review Group (NRG) adopted at the CHMP meeting of 11 December 2025", "type": "chmp-annex", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T15:58:28Z", "last_update_date": "2025-12-17T15:58:28Z", "reference_number": "EMA/394227/2025", "url": "https://www.ema.europa.eu/en/documents/chmp-annex/overview-invented-names-reviewed-november-2025-name-review-group-nrg-adopted-chmp-meeting-11-december-2025_en.pdf"}, {"id": "69085", "name": "Ziihera : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-07-03T10:50:07Z", "last_update_date": "2025-12-17T16:10:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/ziihera-epar-product-information_en.pdf"}, {"id": "71822", "name": "Ziihera : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T16:10:11Z", "last_update_date": "2025-12-17T16:10:11Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/ziihera-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71823", "name": "Presentation - System Demo Q4 2025", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T16:09:39Z", "last_update_date": "2025-12-17T16:09:39Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-system-demo-q4-2025_en.pdf"}, {"id": "71824", "name": "Q&A - System Demo Q4 2025", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T16:11:23Z", "last_update_date": "2025-12-17T16:11:23Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/qa-system-demo-q4-2025_en.pdf"}, {"id": "71755", "name": "Concept Paper on the revision of Annex 3 of the guidelines on Good Manufacturing Practice for Radiopharmaceuticals", "type": "scientific-guideline", "status": "Draft: consultation open", "consultation_date": "2025-12-15 - 2026-02-15", "publish_date": "2025-12-15T11:41:06Z", "last_update_date": "2025-12-17T16:16:23Z", "reference_number": "EMA/INS/GMP/389655/2025", "url": "https://www.ema.europa.eu/en/documents/scientific-guideline/concept-paper-revision-annex-3-guidelines-good-manufacturing-practice-radiopharmaceuticals_en.pdf"}, {"id": "71825", "name": "Shortage Prevention Plan (SPP) and Shortage Mitigation Plan (SMP) pilot report", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T16:19:26Z", "last_update_date": "2025-12-17T16:19:26Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/shortage-prevention-plan-spp-shortage-mitigation-plan-smp-pilot-report_en.pdf"}, {"id": "57218", "name": "Table of decisions of labelling exemption requests falling under article 63 of Directive 2001/83/EC examined by the Quality Review of Documents (QRD) Group", "type": "regulatory-procedural-guideline", "status": "unknown", "consultation_date": "", "publish_date": "2023-01-11T14:13:00Z", "last_update_date": "2025-12-17T13:22:00Z", "reference_number": "EMA/934543/2022 Rev.7", "url": "https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/table-decisions-labelling-exemption-requests-falling-under-article-63-directive-2001-83-ec-examined-quality-review-documents-qrd-group_en.pdf"}, {"id": "71561", "name": "Call for user acceptance testers for the read functionality in the Public Product Management Service (PMS) Application Programming Interface (API)", "type": "other", "status": "Draft: consultation open", "consultation_date": "2025-12-08 - 2026-01-12", "publish_date": "2025-12-08T09:32:29Z", "last_update_date": "2025-12-17T16:20:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/call-user-acceptance-testers-read-functionality-public-product-management-service-pms-application-programming-interface-api_en.pdf"}, {"id": "29593", "name": "List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2012-10-01T14:08:00Z", "last_update_date": "2025-12-17T16:30:00Z", "reference_number": "EMA/630645/2012 Rev. 155", "url": "https://www.ema.europa.eu/en/documents/other/list-european-union-reference-dates-eurd-frequency-submission-periodic-safety-update-reports-psurs_en.xlsx"}, {"id": "7374", "name": "Lucentis : EPAR - All Authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2007-03-14T01:00:00Z", "last_update_date": "2025-12-17T10:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/lucentis-epar-all-authorised-presentations_en.pdf"}, {"id": "27249", "name": "Lucentis : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-08-20T02:00:00Z", "last_update_date": "2025-12-17T12:52:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/lucentis-epar-product-information_en.pdf"}, {"id": "27264", "name": "Lucentis : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2009-08-20T02:00:00Z", "last_update_date": "2025-12-17T12:53:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/lucentis-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71827", "name": "Lucentis : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T16:35:49Z", "last_update_date": "2025-12-17T16:35:49Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/lucentis-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71828", "name": "Lucentis : EPAR – Product information - tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T16:37:39Z", "last_update_date": "2025-12-17T16:37:39Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/lucentis-epar-product-information-tracked-changes_en.docx"}, {"id": "71826", "name": "Mozobil : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-08-20T16:21:21Z", "last_update_date": "2025-12-17T16:24:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/mozobil-epar-product-information_en.pdf"}, {"id": "26168", "name": "Abilify Maintena : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2013-11-28T01:00:00Z", "last_update_date": "2025-12-18T15:16:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/abilify-maintena-epar-product-information_en.pdf"}, {"id": "70883", "name": "Abilify Maintena : EPAR – Product information – tracked changes ", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-10-28T14:07:56Z", "last_update_date": "2025-12-18T08:33:03Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/abilify-maintena-epar-product-information-tracked-changes_en.docx"}, {"id": "42179", "name": "Invokana : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2018-10-03T11:48:00Z", "last_update_date": "2025-12-18T11:54:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/invokana-epar-risk-management-plan_en.pdf"}, {"id": "9353", "name": "Invokana : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2013-11-29T01:00:00Z", "last_update_date": "2025-12-18T14:12:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/invokana-epar-product-information_en.pdf"}, {"id": "20433", "name": "Invokana : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2014-09-04T02:00:00Z", "last_update_date": "2025-12-18T11:56:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/invokana-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "31621", "name": "Invokana : EPAR - Medicine overview", "type": "overview", "status": "unknown", "consultation_date": "", "publish_date": "2013-11-29T01:00:00Z", "last_update_date": "2025-12-18T01:00:00Z", "reference_number": "EMA/277052/2025", "url": "https://www.ema.europa.eu/en/documents/overview/invokana-epar-medicine-overview_en.pdf"}, {"id": "71829", "name": "Invokana-H-C-002649-II-0069 : EPAR - Assessment report - Variation", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-18T08:49:34Z", "last_update_date": "2025-12-18T08:49:34Z", "reference_number": "EMA/273696/2025", "url": "https://www.ema.europa.eu/en/documents/variation-report/invokana-h-c-002649-ii-0069-epar-assessment-report-variation_en.pdf"}, {"id": "71830", "name": "Invokana : EPAR – Product information - tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T09:02:25Z", "last_update_date": "2025-12-18T09:02:25Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/invokana-epar-product-information-tracked-changes_en.docx"}, {"id": "70228", "name": "Alyftrek : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-09-23T13:54:19Z", "last_update_date": "2025-12-18T11:10:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/alyftrek-epar-product-information_en.pdf"}, {"id": "54706", "name": "Breyanzi : EPAR - Medicine Overview", "type": "overview", "status": "unknown", "consultation_date": "", "publish_date": "2022-04-08T15:22:00Z", "last_update_date": "2025-12-18T16:16:00Z", "reference_number": "EMADOC-1829012207-33599", "url": "https://www.ema.europa.eu/en/documents/overview/breyanzi-epar-medicine-overview_en.pdf"}, {"id": "54709", "name": "Breyanzi : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2022-04-08T15:31:00Z", "last_update_date": "2025-12-18T17:30:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/breyanzi-epar-risk-management-plan_en.pdf"}, {"id": "54707", "name": "Breyanzi : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2022-04-08T15:26:00Z", "last_update_date": "2025-12-18T12:15:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/breyanzi-epar-product-information_en.pdf"}, {"id": "67743", "name": "Breyanzi : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-11T08:28:20Z", "last_update_date": "2025-12-18T12:19:30Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/breyanzi-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71831", "name": "Breyanzi-VR-0000265024 : EPAR - Assessment report - Variation", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-18T09:20:07Z", "last_update_date": "2025-12-18T09:20:07Z", "reference_number": "EMADOC-1700519818-2456442", "url": "https://www.ema.europa.eu/en/documents/variation-report/breyanzi-vr-0000265024-epar-assessment-report-variation_en.pdf"}, {"id": "71832", "name": "Breyanzi-H-C-004731-P46-023 : EPAR - Assessment report", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-18T09:22:37Z", "last_update_date": "2025-12-18T09:22:37Z", "reference_number": "EMA/500721/2024", "url": "https://www.ema.europa.eu/en/documents/variation-report/breyanzi-h-c-004731-p46-023-epar-assessment-report_en.pdf"}, {"id": "62259", "name": "Azacitidine Kabi: EPAR - Product Information ", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2024-02-22T14:51:44Z", "last_update_date": "2025-12-18T11:11:11Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/azacitidine-kabi-epar-product-information_en.pdf"}, {"id": "71833", "name": "Azacitidine Kabi : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T09:44:14Z", "last_update_date": "2025-12-18T09:44:14Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/azacitidine-kabi-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "8802", "name": "Caelyx pegylated liposomal : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-03-09T01:00:00Z", "last_update_date": "2025-12-18T17:56:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/caelyx-pegylated-liposomal-epar-product-information_en.pdf"}, {"id": "69918", "name": "Caelyx pegylated liposomal : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-09-02T08:48:49Z", "last_update_date": "2025-12-18T09:50:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/caelyx-pegylated-liposomal-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "33324", "name": "Mepact : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-05-06T02:00:00Z", "last_update_date": "2025-12-18T14:35:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/mepact-epar-product-information_en.pdf"}, {"id": "69345", "name": "Mepact : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-07-17T11:49:56Z", "last_update_date": "2025-12-18T09:55:05Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/mepact-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71174", "name": "Alyftrek : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-11-14T11:10:29Z", "last_update_date": "2025-12-18T10:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/alyftrek-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "21436", "name": "Leflunomide ratiopharm : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2011-01-17T01:00:00Z", "last_update_date": "2025-12-18T13:11:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/leflunomide-ratiopharm-epar-product-information_en.pdf"}, {"id": "39696", "name": "Leflunomide ratiopharm : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2011-03-21T01:00:00Z", "last_update_date": "2025-12-18T13:10:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/leflunomide-ratiopharm-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71834", "name": "EMA/PE/0000232894 : EMA decision of 14 April 2025 on the agreement of a paediatric investigation plan and on the granting of a deferral for adeno-associated viral vector serotype 9 containing the human MECP2 gene", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-18T10:12:49Z", "last_update_date": "2025-12-18T10:12:49Z", "reference_number": "EMADOC-1700519818-2039246", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000232894-ema-decision-14-april-2025-agreement-paediatric-investigation-plan-granting-deferral-adeno-associated-viral-vector-serotype-9-containing-human-mecp2-gene_en.pdf"}, {"id": "71836", "name": "Minutes - Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - 20 November 2025", "type": "minutes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T10:19:17Z", "last_update_date": "2025-12-18T10:19:17Z", "reference_number": "EMA/367781/2025", "url": "https://www.ema.europa.eu/en/documents/minutes/minutes-executive-steering-group-shortages-safety-medicinal-products-mssg-20-november-2025_en.pdf"}, {"id": "71837", "name": "EMA/PE/0000232896 : EMA decision of 21 February 2025 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for antisense oligonucleotide against patatin like phospholipase....sodium salt", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-18T10:19:18Z", "last_update_date": "2025-12-18T10:19:18Z", "reference_number": "EMADOC-1700519818-1911730", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000232896-ema-decision-21-february-2025-agreement-paediatric-investigation-plan-granting-deferral-granting-waiver-antisense-oligonucleotide-against-patatin-phospholipasesodium-salt_en.pdf"}, {"id": "71838", "name": "Cosentyx-PAM-0000301644 : EPAR - Assessment report", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-18T10:26:26Z", "last_update_date": "2025-12-18T10:26:26Z", "reference_number": "EMADOC-1700519818-2769286", "url": "https://www.ema.europa.eu/en/documents/variation-report/cosentyx-pam-0000301644-epar-assessment-report_en.pdf"}, {"id": "59548", "name": "Ebymect : EPAR - Risk-management-plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2015-11-23T14:19:00Z", "last_update_date": "2025-12-18T15:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/ebymect-epar-risk-management-plan_en.pdf"}, {"id": "45348", "name": "Xigduo : EPAR - Risk Management Plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2023-05-26T14:19:00Z", "last_update_date": "2025-12-18T10:32:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/xigduo-epar-risk-management-plan_en.pdf"}, {"id": "47119", "name": "Qtern : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2020-03-25T14:46:00Z", "last_update_date": "2025-12-18T10:25:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/qtern-epar-risk-management-plan_en.pdf"}, {"id": "23191", "name": "Strimvelis : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2017-08-17T16:44:00Z", "last_update_date": "2025-12-18T16:57:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/strimvelis-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71839", "name": "Overview of comments received on \"Guideline on allergen products development for immunotherapy and allergy diagnosis in moderate to low-sized study populations\"", "type": "comments", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T11:05:35Z", "last_update_date": "2025-12-18T11:05:35Z", "reference_number": "(EMA/CHMP/72790/2024)", "url": "https://www.ema.europa.eu/en/documents/comments/overview-comments-received-guideline-allergen-products-development-immunotherapy-allergy-diagnosis-moderate-low-sized-study-populations_en.pdf"}, {"id": "54235", "name": "Saphnelo : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2022-02-21T14:15:00Z", "last_update_date": "2025-12-18T15:16:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/saphnelo-epar-product-information_en.pdf"}, {"id": "54236", "name": "Saphnelo : EPAR - All authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2022-02-21T14:17:00Z", "last_update_date": "2025-12-18T11:55:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/saphnelo-epar-all-authorised-presentations_en.pdf"}, {"id": "56429", "name": "Saphnelo : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2022-10-18T13:38:00Z", "last_update_date": "2025-12-18T15:17:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/saphnelo-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "54237", "name": "Saphnelo : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2022-02-21T14:20:00Z", "last_update_date": "2025-12-18T13:36:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/saphnelo-epar-risk-management-plan_en.pdf"}, {"id": "71840", "name": "Saphnelo-H-C-004975-X-0023 : EPAR - Assessment report - Variation", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-18T11:56:09Z", "last_update_date": "2025-12-18T11:56:09Z", "reference_number": "EMA/348230/2025", "url": "https://www.ema.europa.eu/en/documents/variation-report/saphnelo-h-c-004975-x-0023-epar-assessment-report-variation_en.pdf"}, {"id": "66198", "name": "Absimky : EPAR - Medicine overview", "type": "overview", "status": "unknown", "consultation_date": "", "publish_date": "2024-12-18T13:14:51Z", "last_update_date": "2025-12-18T15:50:00Z", "reference_number": "EMA/536423/2024", "url": "https://www.ema.europa.eu/en/documents/overview/absimky-epar-medicine-overview_en.pdf"}, {"id": "66202", "name": "Absimky : EPAR - Risk Management Plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2024-12-18T13:23:35Z", "last_update_date": "2025-12-18T12:05:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/absimky-epar-risk-management-plan_en.pdf"}, {"id": "65325", "name": "CHMP summary of positive opinion for Absimky", "type": "smop-initial", "status": "Adopted", "consultation_date": "", "publish_date": "2024-10-18T12:00:00Z", "last_update_date": "2025-12-18T12:06:00Z", "reference_number": "EMA/CHMP/448121/2024 ", "url": "https://www.ema.europa.eu/en/documents/smop-initial/chmp-summary-positive-opinion-absimky_en.pdf"}, {"id": "66201", "name": "Absimky : EPAR - Public assessment report", "type": "assessment-report", "status": "Adopted", "consultation_date": "", "publish_date": "2024-12-18T13:21:48Z", "last_update_date": "2025-12-18T12:06:00Z", "reference_number": "EMA/511029/2024", "url": "https://www.ema.europa.eu/en/documents/assessment-report/absimky-epar-public-assessment-report_en.pdf"}, {"id": "66200", "name": "Absimky : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2024-12-18T13:20:05Z", "last_update_date": "2025-12-18T19:24:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/absimky-epar-product-information_en.pdf"}, {"id": "66199", "name": "Absimky : EPAR - All authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2024-12-18T13:18:45Z", "last_update_date": "2025-12-18T12:08:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/absimky-epar-all-authorised-presentations_en.pdf"}, {"id": "68505", "name": "Absimky : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-05-28T19:26:20Z", "last_update_date": "2025-12-18T11:00:02Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/absimky-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71841", "name": "Minutes of the PRAC meeting 27 - 30 October 2025", "type": "minutes", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-18T12:16:18Z", "last_update_date": "2025-12-18T12:16:18Z", "reference_number": "EMA/PRAC/375420/2025", "url": "https://www.ema.europa.eu/en/documents/minutes/minutes-prac-meeting-27-30-october-2025_en.pdf"}, {"id": "71805", "name": "Agenda - Management Board meeting: 17-18 December 2025", "type": "agenda", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T13:40:00Z", "last_update_date": "2025-12-18T12:20:29Z", "reference_number": "EMA/MB/331769/2025", "url": "https://www.ema.europa.eu/en/documents/agenda/agenda-management-board-meeting-17-18-december-2025_en.pdf"}, {"id": "22425", "name": "Name Review Group form - questions and answers", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2013-01-24T12:10:00Z", "last_update_date": "2025-12-18T12:10:00Z", "reference_number": "EMA/741768/2012 Rev.1", "url": "https://www.ema.europa.eu/en/documents/other/name-review-group-form-questions-answers_en.pdf"}, {"id": "30832", "name": "Jentadueto : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2012-08-16T02:00:00Z", "last_update_date": "2025-12-18T02:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/jentadueto-epar-product-information_en.pdf"}, {"id": "68165", "name": "Jentadueto : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-05-08T11:50:56Z", "last_update_date": "2025-12-18T12:22:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/jentadueto-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "22982", "name": "Orgalutran : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2008-02-29T01:00:00Z", "last_update_date": "2025-12-18T17:19:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/orgalutran-epar-product-information_en.pdf"}, {"id": "32215", "name": "Orgalutran : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2008-02-29T01:00:00Z", "last_update_date": "2025-12-18T17:20:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/orgalutran-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71842", "name": "Orgalutran : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T12:28:12Z", "last_update_date": "2025-12-18T12:28:12Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/orgalutran-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71843", "name": "Orgalutran : EPAR – Product information - tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T12:30:12Z", "last_update_date": "2025-12-18T12:30:12Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/orgalutran-epar-product-information-tracked-changes_en.docx"}, {"id": "71844", "name": "Cetrotide : EPAR – Product information - tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T12:34:25Z", "last_update_date": "2025-12-18T12:34:25Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cetrotide-epar-product-information-tracked-changes_en.docx"}, {"id": "17698", "name": "RotaTeq : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-12-04T00:09:00Z", "last_update_date": "2025-12-18T17:41:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/rotateq-epar-product-information_en.pdf"}, {"id": "67995", "name": "RotaTeq : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-25T16:26:37Z", "last_update_date": "2025-12-18T12:55:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/rotateq-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71845", "name": "Prazepam : List of nationally authorised medicinal products - PSUSA/00002502/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T12:57:21Z", "last_update_date": "2025-12-18T12:57:21Z", "reference_number": "EMADOC-1700519818-2770702", "url": "https://www.ema.europa.eu/en/documents/psusa/prazepam-list-nationally-authorised-medicinal-products-psusa-00002502-202503_en.pdf"}, {"id": "71846", "name": "Prazepam : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00002502/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T12:58:59Z", "last_update_date": "2025-12-18T12:58:59Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/psusa/prazepam-cmdh-scientific-conclusions-grounds-variation-amendments-product-information-timetable-implementation-psusa-00002502-202503_en.pdf"}, {"id": "71733", "name": "Questions and answers on the refusal of the marketing authorisation for Blarcamesine Anavex", "type": "smop-initial", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T14:00:00Z", "last_update_date": "2025-12-18T13:25:00Z", "reference_number": "EMA/385732/2025", "url": "https://www.ema.europa.eu/en/documents/smop-initial/questions-answers-refusal-marketing-authorisation-blarcamesine-anavex_en.pdf"}, {"id": "71850", "name": "Fetcroja-PAM-0000303390 : EPAR - Assessment report", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-18T14:12:48Z", "last_update_date": "2025-12-18T14:12:48Z", "reference_number": "EMADOC-1700519818-2517542", "url": "https://www.ema.europa.eu/en/documents/variation-report/fetcroja-pam-0000303390-epar-assessment-report_en.pdf"}, {"id": "59513", "name": "List of medicines currently in PRIME scheme", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2016-10-17T17:41:00Z", "last_update_date": "2025-12-18T14:30:00Z", "reference_number": "EMA/521657/2016", "url": "https://www.ema.europa.eu/en/documents/other/list-medicines-currently-prime-scheme_en.xlsx"}, {"id": "71851", "name": "Recommendations on eligibility to PRIME scheme Adopted at the CHMP meeting of 8-11 December 2025", "type": "chmp-annex", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-18T14:27:07Z", "last_update_date": "2025-12-18T14:27:07Z", "reference_number": "EMA/371701/2025", "url": "https://www.ema.europa.eu/en/documents/chmp-annex/recommendations-eligibility-prime-scheme-adopted-chmp-meeting-8-11-december-2025_en.pdf"}, {"id": "71852", "name": "Summary of bilateral meeting: European Medicines Agency and the European Consumer Organisation (BEUC)", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T15:16:51Z", "last_update_date": "2025-12-18T15:16:51Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/summary-bilateral-meeting-european-medicines-agency-european-consumer-organisation-beuc_en.pdf"}, {"id": "71853", "name": "Agenda - EMA/BEUC Bilateral", "type": "agenda", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T15:18:11Z", "last_update_date": "2025-12-18T15:18:11Z", "reference_number": "EMA/230706/2025", "url": "https://www.ema.europa.eu/en/documents/agenda/agenda-ema-beuc-bilateral_en.pdf"}, {"id": "27303", "name": "Puregon : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-07-31T02:00:00Z", "last_update_date": "2025-12-18T17:19:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/puregon-epar-product-information_en.pdf"}, {"id": "70953", "name": "Puregon : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-10-30T17:19:06Z", "last_update_date": "2025-12-18T15:24:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/puregon-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "36387", "name": "Puregon : EPAR - All authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2008-08-31T02:00:00Z", "last_update_date": "2025-12-18T15:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/puregon-epar-all-authorised-presentations_en.pdf"}, {"id": "66197", "name": "Afqlir : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-01-20T11:54:28Z", "last_update_date": "2025-12-18T15:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/afqlir-epar-product-information_en.pdf"}, {"id": "67963", "name": "Afqlir : EPAR -Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-24T16:52:28Z", "last_update_date": "2025-12-18T16:01:47Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/afqlir-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}]}